Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2014
02/06/2014US20140039009 Compounds for inflammation and immune-related uses
02/06/2014US20140039007 Compositions and methods for modulating farnesoid x receptors
02/06/2014US20140039005 Novel rebamipide complexes and cocrystals
02/06/2014US20140039004 Method of treating of gastroesophageal reflux disease
02/06/2014US20140039003 Treatment of glaucoma
02/06/2014US20140039000 Liquid pharmaceutical formulations of palonosetron
02/06/2014US20140038998 Stabilized tacrolimus composition
02/06/2014US20140038997 Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
02/06/2014US20140038996 Freeze Dried Drug Nanosuspensions
02/06/2014US20140038992 Methods of administering raltegravir and raltegravir compositions
02/06/2014US20140038991 Protein Kinase Inhibitors
02/06/2014US20140038990 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
02/06/2014US20140038989 Tetrahydropyrazolo [1,5-a] pyrimidine as anti-tuberculosis compounds
02/06/2014US20140038988 Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
02/06/2014US20140038985 Treatment regimens
02/06/2014US20140038984 Compositions and Methods for the Treatment of Metabolic and Related Disorders
02/06/2014US20140038982 Cancer treatment method
02/06/2014US20140038980 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
02/06/2014US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
02/06/2014US20140038974 Compositions and Methods for Eye Whitening
02/06/2014US20140038973 Compositions and Methods for Eye Whitening
02/06/2014US20140038972 Alpha-2 agonist polymeric drug delivery systems
02/06/2014US20140038971 Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
02/06/2014US20140038967 Novel use for imidazotriazinones
02/06/2014US20140038966 Tegafur-containing composition for single daily and alternate-day dosing
02/06/2014US20140038959 Methods of treating tumors
02/06/2014US20140038958 Cdk8-cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer
02/06/2014US20140038956 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc).
02/06/2014US20140038949 Directed differentiation of oligodendrocyte precursor cells to a myelinating cell fate
02/06/2014US20140038948 Compounds and methods for kinase modulation, and indications therefor
02/06/2014US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines
02/06/2014US20140038943 Serotonin receptor modulator
02/06/2014US20140038942 RORgammaT INHIBITORS
02/06/2014US20140038940 Novel egfr modulators and uses thereof
02/06/2014US20140038939 Triazolopyridine jak inhibitor compounds and methods
02/06/2014US20140038935 Dihydrodiazepines useful as inhibitors of protein kinases
02/06/2014US20140038932 Synthetic bile acid compositions and methods
02/06/2014US20140038930 Androgen treatment in females
02/06/2014US20140038929 Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction
02/06/2014US20140038928 5-(2--1-hydroxyethyl-8-hydroxyquinolin-2 (1h)-one and its use in the treatment of pulmonary diseases
02/06/2014US20140038927 Compositions for treating neurological disorders
02/06/2014US20140038926 Heteroaryl-Ketone Fused Azadecalin Glucocorticoid Receptor Modulators
02/06/2014US20140038924 Anti-Thrombotic Compounds
02/06/2014US20140038921 New low side effect pharmaceutical composition containing antituberculosis drugs
02/06/2014US20140038920 Tfeb phosphorylation inhibitors and uses thereof
02/06/2014US20140038919 Hepatitis c inhibitors and uses thereof
02/06/2014US20140038918 Treatments for retinal disorders
02/06/2014US20140038917 Sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
02/06/2014US20140038916 O-(substituted benzyl) phosphoramidate compounds and therapeutic use
02/06/2014US20140038915 Methods for treating bacterial infection
02/06/2014US20140038914 Compounds for use in the treatment of bacterial infection
02/06/2014US20140038913 Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism
02/06/2014US20140038911 Pharmaceutical composition, methods for treating and uses thereof
02/06/2014US20140038909 Tissue occluding agent
02/06/2014US20140038889 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
02/06/2014US20140038888 Pharmaceutical combinations for the treatment of metabolic disorders
02/06/2014US20140038883 Novel azacoumarin derivatives having mdr pump inhibiting activity
02/06/2014US20140038821 Isoxazolines for controlling invertebrate pests
02/06/2014US20140037772 Cosmetic or Pharmaceutical Formulation
02/06/2014US20140037771 Composition Comprising Retinol, a Precursor or a Reaction Product of it and a Plant Extract from at least one Chamomilla Plant for the Treatment of Cancer
02/06/2014US20140037769 Method for manufacturing pure guar flour
02/06/2014US20140037767 Natural - Topical analgesic and anti-inflammatory composition F2
02/06/2014US20140037763 Annatto Extract Compositions Including Tocotrienols and Tocopherols and Methods of Use
02/06/2014US20140037760 Methods of inducing stasis for the treatment of cancer
02/06/2014US20140037758 Skin external composition comprising a melted salt and suagr as active ingredients for preventing and treating vaginosis and the use thereof
02/06/2014US20140037757 Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits
02/06/2014US20140037755 Mapkap Kinase-2 as a Specific Target for Blocking Proliferation of P53-Defective Cells
02/06/2014US20140037754 Aminopyrimidines useful as kinase inhibitors
02/06/2014US20140037746 Polymer-based, sustained release drug delivery system
02/06/2014US20140037745 Controlled release compositions of gamma-hydroxybutyrate
02/06/2014US20140037744 Microcapsules containing an oxidizable active, and a process for preparing the same
02/06/2014US20140037743 Microencapsulated bioactive agents for oral delivery and methods of use thereof
02/06/2014US20140037740 Controlled release pharmaceutical compositions comprising a fumaric acid ester
02/06/2014US20140037739 Method and System to Provide Personalized Pharmaceutical Compositions and Dosages
02/06/2014US20140037738 Transdermal formulation containing cox inhibitors
02/06/2014US20140037735 Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
02/06/2014US20140037731 Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery
02/06/2014US20140037730 Compositions for the symptomatic relief of stomach pain or gastrooesophageal reflux
02/06/2014US20140037729 Combination of an opioid agonist and an opioid antagonist in the treatment of parkinson's disease
02/06/2014US20140037728 Dosage forms for oral administration and methods of treatment using the same
02/06/2014US20140037727 Tablet Of Paracetamol Containing An Encapsulated Flavorant
02/06/2014US20140037726 Novel pharmaceutical composition
02/06/2014US20140037725 Bilayer pharmaceutical compositions of naproxen
02/06/2014US20140037724 Unitary pharmaceutical dosage form
02/06/2014US20140037723 Low Dose Topiramate/Phentermine Composition And Methods Of Use Thereof
02/06/2014US20140037722 Methods and compositions of camel derived products
02/06/2014US20140037721 Pharmaceutical Composition
02/06/2014US20140037720 Controlled release pharmaceutical compositions comprising a fumaric acid ester
02/06/2014US20140037719 Stabilized pharmaceutical formulations of a potent hcv inhibitor
02/06/2014US20140037718 Transdermal pain gel
02/06/2014US20140037715 Disulfiram formulation and uses thereof
02/06/2014US20140037713 Transdermal compositions for anti-cholinergic agents
02/06/2014US20140037700 Composition and Method for Enhancing an Immune Response
02/06/2014US20140037698 Additives for animal food
02/06/2014US20140037697 Particulate materials
02/06/2014US20140037685 Adjuvants that activate adaptive immune system by stimulating nlrp3
02/06/2014US20140037654 Therapeutic method and medicament for htlv-1 associated myelopathy (ham)
02/06/2014US20140037653 Modulation of lrch4 activity and therapeutic application thereof
02/06/2014US20140037635 Methods of treatment using il-17e antagonists
02/06/2014US20140037627 Modulation of pilr receptors to treat microbial infections
1 ... 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 ... 7860